Life Sciences Specialty Product Analysis
Specialty product analysis from SGS provides expertise for a variety of products, including controlled substances, cytotoxic, antibiotics, medical devices, and both small and large pharmaceuticals.
To develop and bring your medical products to market, you need expert support. Our specialty product testing services help you innovate and progress through discovery, pre-clinical, clinical and final release. Our technical specialists have the expertise to support the multiphase testing of a wide range of products – from biosimilars and vaccines to controlled and cytotoxic materials.
Our integrated laboratory network offers an extensive portfolio of analytical testing support during drug development, including:
- Antibody analysis
- Biosimilar testing services
- Controlled substance analysis
- Nucleic acid analysis
- Oligonucleotide analysis
- Vaccine testing services
- Oligosaccharide analyses
- Antibiotic testing
- Medical device testing
- Peptide and protein testing
- Heavy metal testing
- Container testing
- Steroid analyses
- Pharmaceutical testing of all types
- Cytotoxic testing
We provide a comprehensive partnership with access to technical and laboratory proficiency, including areas of unique speciality and world-leading global experts to guide you through the testing of your specific drug product.
We also offer flexible business development solutions for your specific requirements, including:
- Up-front consultation: discuss technical and regulatory aspects of testing with our panels of experts
- Business development: elect the most appropriate working partnership, from “fee-for-service” to FTE models
To discuss your requirements and the available partnership options, contact us today.